Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Analgesia for Postoperative Pain
NCT03817034Phase 1Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2021
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label, single-arm trial of dexmedetomidine, ropivacaine and ketorolac in postoperative pain, sponsored by Massachusetts General Hospital. Primary endpoints: Change in post-operative opioid consumption at 48 hours and Change in post-operative pain scores at 48 hours. Planned start Mar 2021; status: withdrawn.
02
Drugs
dexmedetomidineropivacaineketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03817034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03817034.